ELV logo

ELV
Elevance Health Inc

4,761
Mkt Cap
$79.73B
Volume
4.06M
52W High
$458.75
52W Low
$273.71
PE Ratio
15.07
ELV Fundamentals
Price
$349.75
Prev Close
$354.07
Open
$344.70
50D MA
$322.67
Beta
0.30
Avg. Volume
2.01M
EPS (Annual)
$25.68
P/B
1.82
Rev/Employee
$1.7M
Loading...
Loading...
News
all
press releases
Elevance Health Q3 Earnings Beat Estimates on Strong MA Membership
ELV beats EPS estimates by 21% in Q3 as strong Medicare Advantage membership gains and Carelon revenue growth offset Medicaid losses.
Zacks·6h ago
News Placeholder
More News
News Placeholder
Elevance Health (ELV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·11h ago
News Placeholder
Elevance Health (ELV) Tops Q3 Earnings and Revenue Estimates
Elevance Health (ELV) delivered earnings and revenue surprises of +21.08% and +1.15%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·13h ago
News Placeholder
Elevance Health Reports Third Quarter 2025 Results
Elevance Health, Inc. (NYSE: ELV) reported third quarter 2025 results. 'Our third quarter results were in line with expectations and reflect disciplined execution across Elevance Health. In a dynamic...
Business Wire·14h ago
News Placeholder
Should You Add CVS Health Stock to Your Portfolio Before Q3 Earnings?
CVS Health prepares Q3 results, with pharmacy performance and Aetna's progress in focus for investors.
Zacks·5d ago
News Placeholder
Wall Street's Insights Into Key Metrics Ahead of Elevance Health (ELV) Q3 Earnings
Besides Wall Street's top-and-bottom-line estimates for Elevance Health (ELV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Zacks·5d ago
News Placeholder
Will Rising Costs Hurt Elevance's Q3 Earnings Despite Higher Premiums?
ELV's third-quarter earnings may face pressure as rising costs and weaker Medicaid memberships offset premium gains.
Zacks·6d ago
News Placeholder
Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·6d ago
News Placeholder
NYSE: ELV Lawsuit Update: Investors in Elevance Health, Inc. (NYSE: ELV) shares should contact the Shareholders Foundation in connection with pending Lawsuit
NYSE: ELV Lawsuit Update: Investors in Elevance Health, Inc. (NYSE: ELV) shares should contact the Shareholders Foundation in connection with pending Lawsuit NYSE: ELV Lawsuit Update: Investors in...
PR Newswire·7d ago
News Placeholder
Analysts Estimate Elevance Health (ELV) to Report a Decline in Earnings: What to Look Out for
Elevance Health (ELV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·7d ago

Latest ELV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.